COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS

COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS

Show other versions (1)

Atopic dermatitis (ad) is prevalent disease in younger children. Calcium inhibitor pimecrolimus (elidel, cream 1%) is the latest anti-inflammatory drug offered for management of ad. The activity of pimecrolimus was evaluated in open, prospective, randomized, comparison trial, on 60 children (age fro...

Full description

Bibliographic Details
Main Authors:	E.V. Deeva, L.M. Ogorodova, I.A. Deev, I.V. Sheveleva
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2008-04-01
Series:	Вопросы современной педиатрии
Online Access:	https://vsp.spr-journal.ru/jour/article/view/1368

Similar Items

COMPARISON OF CLINICAL ACTIVITY OF PIMECROLIMUS IN PEDIATRIC PATIENTS WITH MILD AND MODERATE ATOPIC DERMATITIS
by: E.V. Deeva, et al.
Published: (2008-01-01)

ATOPIC DERMATITIS AMONG CHILDREN: ZONE OF CLINICAL SUPERVISION
by: L.M. Ogorodova, et al.
Published: (2007-01-01)

ATOPIC DERMATITIS AMONG CHILDREN: ZONE OF CLINICAL SUPERVISION
by: L.M. Ogorodova, et al.
Published: (2007-11-01)

Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
by: Chia-Yu Chu, et al.
Published: (2023-02-01)

EFFECTIVENESS AND SAFETY OF PIMECROLIMUS IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN AND ADOLESCENTS
by: K.N. Monakhov, et al.
Published: (2008-01-01)

EFFECTIVENESS AND SAFETY OF PIMECROLIMUS IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN AND ADOLESCENTS
by: K.N. Monakhov, et al.
Published: (2008-12-01)

Substantiation of Using Pimecrolimus 1% Cream in Proactive Therapy of Children with Atopic Dermatitis
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01)

Retraction: Pimecrolimus cream 1% in the management of atopic dermatitis in pediatric patients: a meta-analysis.
by: PLOS ONE Editors
Published: (2014-01-01)

PIMECROLIMUS APPLICATION IN TREATMENT FOR ATOPIC DERMATITIS DURING LOCALIZATION OF THE SKIN RASH IN AREAS WITH THIN AND SENSITIVE SKIN
by: O.V. Trusova, et al.
Published: (2007-07-01)

PIMECROLIMUS APPLICATION IN TREATMENT FOR ATOPIC DERMATITIS DURING LOCALIZATION OF THE SKIN RASH IN AREAS WITH THIN AND SENSITIVE SKIN
by: O.V. Trusova, et al.
Published: (2007-01-01)

Pimecrolimus cream in the management of patients with atopic eczema
by: Jonathan M Spergel
Published: (2009-05-01)

Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
by: Joseph Fowler, et al.
Published: (2023-02-01)

EPIDEMIOLOGICAL AND CLINICAL PECULIARITIES OF ATOPIC DERMATITIS IN CHILDREN IN ENDEMIC REGION WITH OPISTHORCHIASIS
by: L.M. Ogorodova, et al.
Published: (2010-01-01)

EPIDEMIOLOGICAL AND CLINICAL PECULIARITIES OF ATOPIC DERMATITIS IN CHILDREN IN ENDEMIC REGION WITH OPISTHORCHIASIS
by: L.M. Ogorodova, et al.
Published: (2010-05-01)

Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life
by: Nikolay N. Murashkin, et al.
Published: (2023-04-01)

Treatment preferences among patients with mild-to-moderate atopic dermatitis
by: Kelley Myers, et al.
Published: (2023-12-01)

Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
by: Nari Shin, et al.
Published: (2021-08-01)

Treatment of Mild to Moderate Plaque Psoriasis with Pimecrolimus, Clobetasol, or Calcipotriol Cream: A comparative study
by: Bahir A.R. Mshimesh
Published: (2016-04-01)

Oxidative stress as a treatment target in atopic dermatitis: The role of furfuryl palmitate in mild-to-moderate atopic dermatitis
by: Adelaide A. Hebert, MD
Published: (2020-09-01)

Comorbidities in pediatric atopic dermatitis
by: Eliza I Pope, et al.
Published: (2018-01-01)

Effects of NB-UVB with pimecrolimus cream on the expression of eotaxin in serum and CCR3 on peripheral blood monocytes in patients with adult atopic dermatitis
by: Yan YANG, et al.
Published: (2020-02-01)

Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study
by: Xia Dou, et al.
Published: (2023-12-01)

Pimecrolimus in the clinical practice of a dermatologist
by: N. M. Sharova, et al.
Published: (2022-07-01)

Evaluation of “Steroid-Sparing” Effects of Xanthena® Cream in Patients with Mild to Moderate Atopic Dermatitis
by: N. Cassano, et al.
Published: (2003-01-01)

The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation
by: R Garside, et al.
Published: (2005-07-01)

Prevalence of dental caries in pediatric patients with atopic dermatitis
by: T.M. Volosovets, et al.
Published: (2023-05-01)

Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023-06-01)

Paediatric atopic eczema (atopic dermatitis) in South Africa: A practical algorithm for the management of mild-to-moderate disease in daily clinical practice
by: Susanna M. Kannenberg, et al.
Published: (2020-11-01)

Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
by: Lawrence F. Eichenfield, et al.
Published: (2024-03-01)

Atopic dermatitis and sexual behavior of women
by: Astafieva N.G., et al.
Published: (2013-09-01)

Biologic Therapy of Moderate and Severe Forms of Atopic Dermatitis in Children
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Current views on the pathogenesis and treatment of atopic dermatitis in adults. Experience with the JAK inhibitor baricitinib in patients with moderate to severe atopic dermatitis
by: E. V. Svechnikova, et al.
Published: (2022-04-01)

Research Progress of Bathing in Pediatric Atopic Dermatitis
by: LIU Zhengqiang, et al.
Published: (2023-07-01)

Treating pediatric atopic dermatitis: current perspectives
by: Dimitriades VR, et al.
Published: (2015-06-01)

Evaluation of the Impact of Serum Vitamin D Levels on the Scoring Atopic Dermatitis Index in Pediatric Atopic Dermatitis
by: Fatih Çiçek, et al.
Published: (2023-09-01)

Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
by: Mahreen Ameen, et al.
Published: (2024-02-01)

Association of moderate–severe atopic dermatitis with dental anomalies
by: Sean Y Tan, et al.
Published: (2022-01-01)

Co-occurrence network analysis reveals the alterations of the skin microbiome and metabolome in adults with mild to moderate atopic dermatitis
by: Paulo Wender P. Gomes, et al.
Published: (2024-03-01)

Description of Hanifin-Rajka Criteria and Skin Hydration in Adult Patients with Mild-Moderate Atopic Dermatitis at Tertiary Hospital
by: Menul Ayu Umborowati, et al.
Published: (2024-03-01)

Prediction of disease severity using serum biomarkers in patients with mild-moderate Atopic Dermatitis: A pilot study.
by: In-Seon Lee, et al.
Published: (2023-01-01)